A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: RPT193;   Drug: Placebo Sponsor:   RAPT Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials